Tevogen Bio (TVGN) Competitors

Tevogen Bio (NASDAQ:TVGN) and Syndax Pharmaceuticals (NASDAQ:SNDX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, risk and dividends.

Does the media favor TVGN or SNDX?

In the previous week, Tevogen Bio had 6 more articles in the media than Syndax Pharmaceuticals. MarketBeat recorded 10 mentions for Tevogen Bio and 4 mentions for Syndax Pharmaceuticals. Syndax Pharmaceuticals' average media sentiment score of 1.33 beat Tevogen Bio's score of 0.48 indicating that Syndax Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tevogen Bio	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syndax Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, TVGN or SNDX?

Tevogen Bio has a beta of -0.69, indicating that its share price is 169% less volatile than the S&P 500. Comparatively, Syndax Pharmaceuticals has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.

Is TVGN or SNDX more profitable?

Syndax Pharmaceuticals' return on equity of -64.34% beat Tevogen Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tevogen Bio	N/A	-396.07%	749.97%
Syndax Pharmaceuticals	N/A	-64.34%	-57.72%

Does the MarketBeat Community prefer TVGN or SNDX?

Syndax Pharmaceuticals received 384 more outperform votes than Tevogen Bio when rated by MarketBeat users. However, 100.00% of users gave Tevogen Bio an outperform vote while only 65.22% of users gave Syndax Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Tevogen Bio	Outperform Votes 8 100.00%	Underperform Votes No Votes
Syndax Pharmaceuticals	Outperform Votes 392 65.22%	Underperform Votes 209 34.78%

Do analysts recommend TVGN or SNDX?

Tevogen Bio currently has a consensus target price of $7.10, suggesting a potential upside of 429.85%. Syndax Pharmaceuticals has a consensus target price of $35.91, suggesting a potential upside of 229.44%. Given Tevogen Bio's stronger consensus rating and higher possible upside, equities analysts plainly believe Tevogen Bio is more favorable than Syndax Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tevogen Bio	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Syndax Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.91

Which has higher earnings and valuation, TVGN or SNDX?

Tevogen Bio has higher earnings, but lower revenue than Syndax Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tevogen Bio	N/A	N/A	-$70K	N/A	N/A
Syndax Pharmaceuticals	$43.72M	21.45	-$209.36M	-$3.86	-2.82

Summary

Tevogen Bio and Syndax Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.